Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-05-30 | New | $147,017,491 | $147,017,491 | Equity Only | 06b | SEC link |
| 2023-06-08 | New | $500,000 | $500,000 | Equity Only | 06b | SEC link |
| 2022-05-20 | New | $500,000 | $500,000 | Equity Only | 06b | SEC link |
| 2021-11-12 | New | $850,000 | $850,000 | Equity Only | 06b | SEC link |
| 2021-08-02 | New | $1,050,000 | Unknown | Other | SEC link | |
| 2020-08-26 | New | $2,375,000 | $2,375,000 | Equity Only | 06b | SEC link |
| 2019-10-22 | New | $602,402 | $602,402 | Equity Only | 06b | SEC link |
| 2019-06-24 | New | $2,000,000 | $2,000,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Kristina Andrijauskaite | Executive |
| Leon Bunegin | Director, Executive |
| Tom De Brooke | Director, Executive |
| Toni Haenninen | Executive |
| Celia Jairala | Director |
| C. Thomas Mayes | Director, Executive |
| Mark Muller | Director |
| Paul Perry | Executive |
| Rafael Veraza | Director, Executive |
| Klaus Weiswurm | Director |